Royalty Pharma plc
$33.54B- Market cap
- $24.82B
- Debt
- +$9.33B
- Cash
- −$618.70M
Capital structure 73% equity / 27% debt · EV / Revenue 14.10x · EV / EBITDA 31.91x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
RPRX · current priceP/E 35.93x
$63.96Latest market snapshot
Implied fair value · at PH's multiple
$60.165.9% below market
1.78 RPRX EPS (TTM)×33.80x PH P/E=$60.16
Market $63.96Implied $60.16
PH · current priceP/E 33.80x
$962.59Latest market snapshot
Implied fair value · at RPRX's multiple
$1,023.366.3% above market
28.48 PH EPS (TTM)×35.93x RPRX P/E=$1,023.36
Market $962.59Implied $1,023.36